| Literature DB >> 23551777 |
Vince Lau1, Michael Sun, Ferdinand Chu.
Abstract
Bone tumours, either primary or secondary, can present in various debilitating manners, including pain and pathological fracture. The situation is particularly problematic when the tumours are hypervascular, and located in regions where a high risk of neurological compromise is anticipated during operation, such as in the spine or sacrum. In such situations, bone tumour embolisation is a useful and effective adjunctive treatment for reducing intra-operative blood loss. This is particularly relevant in primary bone tumours such as giant cell tumours and metastatic renal cell and thyroid tumours. With a proper pre-embolisation angiogram and knowledge of anatomy, careful selective cannulation of the arterial supplies and experience in using embolic agents, the risks of non-target embolisation can be kept to minimum and the best result achieved.Entities:
Mesh:
Year: 2012 PMID: 23551777 DOI: 10.1111/j.1754-9485.2012.02444.x
Source DB: PubMed Journal: J Med Imaging Radiat Oncol ISSN: 1754-9477 Impact factor: 1.735